大禹生物：2026年第一次临时股东会决议公告

Core Viewpoint - Dayu Biological announced the approval of several proposals at its first extraordinary shareholders' meeting in 2026, including the conclusion of certain fundraising projects and the allocation of surplus funds to supplement working capital [2] Group 1: Proposals Approved - The company approved the proposal to conclude certain fundraising projects and permanently allocate surplus funds to working capital [2] - The company also approved a proposal regarding expected routine related-party transactions for 2026 [2] - Additionally, the company approved a proposal to apply for comprehensive credit facilities from banks, other financial institutions, and leasing companies in 2026 [2]